ANY LAB TEST NOW AND ARCPOINT CREATE LARGEST FRANCHISE DIRECT ACCESS LAB TESTING GROUP IN THE UNITED STATES
ANY LAB TEST NOW AND ARCPOINT CREATE LARGEST FRANCHISE DIRECT ACCESS LAB TESTING GROUP IN THE UNITED STATES
Greenville, South Carolina, Aug. 20, 2024 (GLOBE NEWSWIRE) -- ARCpoint Inc. (TSXV: ARC) (the "Company" or "ARCpoint") is pleased to announce that it has entered into a transaction, dated August 20, 2024, with Any Lab Test Now, ("ALTN") and is finalizing the process to bring together the franchise operations of both companies into a new joint venture company, CRESSO Brands, LLC. ("CRESSO").
南卡羅來納州格林維爾,2024年8月20日(GLOBE NEWSWIRE)——ArcPoint Inc.(多倫多證券交易所股票代碼:ARC)(「公司」 或 「ArcPoint」)欣然宣佈,它已於2024年8月20日與Any Lab Test Now(「ALTN」)達成交易,並正在完成將兩家公司的特許經營業務合併爲一家新的合資公司CRESSO的程序 Brands, LLC。(「CRESSO」)。
Any Lab Test Now CEO, Clarissa Bradstock, commented "By combining our two franchise operations, we will not only create the largest franchise network of its kind in the United States, but we expect to capitalize on the respective strengths of both franchise groups to improve both individual unit and overall economic performance. As a collaborative group, we believe that ARCpoint franchisees will benefit from the Any Lab Test Now experience gained in successfully building our mostly individual consumer business. At the same time, we believe that Any Lab Test Now franchisees will benefit from the implementation of ARCpoint's proprietary technology platform, MyARCpointLabs, as well as ARCpoint's experience in the B2B and employer solutions markets".
Any Lab Test Now首席執行官克拉麗莎·布拉德斯托克評論說:「通過合併我們的兩家特許經營業務,我們不僅將創建美國同類中最大的特許經營網絡,而且我們希望利用兩個特許經營集團各自的優勢來改善個別單位和整體經濟表現。作爲一個協作小組,我們相信,ArcPoint加盟商將受益於成功建立我們以個人爲主的消費者業務所獲得的Any Lab Test Now的經驗。同時,我們相信,Any Lab Test Now的加盟商將受益於ArcPoint專有技術平台MyArcPointLabs的實施以及ArcPoint在B20和僱主解決方案市場的經驗」。
Any Lab Test Now, ("ALTN") based in Atlanta, Georgia, was founded in 1992. It currently has more than 235 U.S. franchise locations providing direct access to clinical, DNA, and drug and alcohol lab testing services, as well as phlebotomy and other specimen collection services, through its retail storefront business model. ALTN has been recognized as one of the top 500 franchises for nine consecutive years in Entrepreneur's Franchise 500. Entrepreneur magazine's Franchise 500 is the world's first, best and most comprehensive franchise ranking. It is not intended to endorse, advertise, or recommend any particular franchise and is solely a tool to compare franchise operations.
Any Lab Test Now(「ALTN」)成立於1992年,總部位於佐治亞州亞特蘭大。它目前在美國擁有超過235個特許經營地點,通過其零售店面商業模式直接提供臨床、DNA、藥物和酒精實驗室測試服務,以及放血和其他樣本採集服務。ALTN連續九年被企業家特許經營500強評爲500強特許經營權之一。《企業家》雜誌的《特許經營500強》是世界上第一個、最佳和最全面的特許經營排名。它無意認可、宣傳或推薦任何特定的特許經營權,僅是比較特許經營業務的工具。
ARCpoint CEO, John Constantine added "In addition to the cost benefits and efficiencies of combining our respective franchise operations under CRESSO, we believe this partnership is very positive to ARCpoint shareholders in the near term as it will allow us to reduce ARCpoint's costs, while at the same time adding a new customer to our MyARCPointLabs technology platform and increasing our distribution footprint".
ArcPoint首席執行官約翰·康斯坦丁補充說:「除了將我們各自的特許經營業務合併到CRESSO下可以帶來成本效益和效率外,我們認爲這種夥伴關係在短期內對ArcPoint股東來說非常積極,因爲這將使我們能夠降低ArcPoint的成本,同時爲我們的MyArcPoint技術平台增加新客戶並擴大我們的分銷範圍」。
Under the terms of the agreement, both ARCpoint and ALTN have contributed their franchise operations into CRESSO Brands, LLC, a Delaware limited liability company. ALTN will own 70.5% of the new entity, with ARCpoint owning the other 29.5%. Both ALTN and the ARCpoint Franchise Group ("AFG") brands will remain and be managed on a separate basis. Clarissa Bradstock will continue to lead ALTN, as she has for the past 11 years and Bob Mann will continue to lead AFG, as he has done since April 2023. In addition to continuing his role as ARCpoint CEO, John Constantine will also act as Implementation Strategist for CRESSO and split his time with ARCpoint. Both ALTN and AFG management teams will report to a CRESSO board of directors, which will be comprised of a total of five members. Of the five directors, three will be appointed by ALTN and two by ARCpoint. The ARCpoint nominees will be John Constantine and Bob Mann.
根據協議條款,ArcPoint和ALTN均將其特許經營業務出資給了特拉華州有限責任公司CRESSO Brands, LLC。ALTN將擁有新實體70.5%的股份,ArcPoint將擁有另外29.5%的股份。ALTN和ArcPoint特許經營集團(「AFG」)品牌都將保留並分開管理。克拉麗莎·布拉德斯托克將像過去11年一樣繼續領導ALTN,鮑勃·曼恩將繼續領導AFG,就像他自2023年4月以來所做的那樣。除了繼續擔任ArcPoint首席執行官外,約翰·康斯坦丁還將擔任CRESSO的實施策略師,並將時間分散在ArcPoint工作。ALTN和AFG管理團隊都將向CRESSO董事會報告,該董事會將由總共五名成員組成。在五名董事中,三名將由ALTN任命,兩名由ArcPoint任命。ArcPoint的提名人將是約翰·康斯坦丁和鮑勃·曼恩。
Separately, ALTN and ARCpoint have agreed to make ARCpoint's MyARCPointLabs technology platform the system's choice for CRESSO brand franchisees.
另外,ALTN和ArcPoint已同意將ArcPoint的MyArcPointLabs技術平台作爲CRESSO品牌加盟商的系統選擇。
Any Lab Test Now is an Arms Length party to ARCpoint and there are no finder's fees payable in connection with this transaction.
Any Lab Test Now 是 ArcPoint 的 Arms Length 參與方,本次交易無需支付任何發現者費用。
About ANY LAB TEST NOW
Founded in 1992, ANY LAB TEST NOW is a franchise direct access lab testing company that provides thousands of standard lab tests to consumers and businesses in a professional, convenient, cost-effective, and transparent manner with more than 235 franchises around the United States. ANY LAB TEST NOW offers a variety of affordable and confidential lab tests to consumers and businesses, including blood, drug, DNA, and STD testing. To learn more about lab testing near you visit
關於立即進行任何實驗室測試
ANY Lab Test NOW成立於1992年,是一家特許經營的直接訪問實驗室測試公司,以專業、便捷、經濟實惠和透明的方式向消費者和企業提供數千種標準實驗室測試,在美國擁有超過235家特許經營權。ANY Lab Test現在爲消費者和企業提供各種價格合理且保密的實驗室測試,包括血液、藥物、DNA和性病檢測。要了解有關您附近的實驗室測試的更多信息,請訪問
About ARCpoint Inc.
ARCpoint is a leading US-based franchise system providing drug testing, alcohol screening, DNA and clinical lab testing, corporate wellness programs, and employment and background screening, among other services. The Company is based in Greenville, South Carolina, USA. ARCpoint Franchise Group LLC, formed under the laws of the state of South Carolina in February 2005, is the franchisor of ARCpoint Labs and supports over 130 independently owned locations. ARCpoint sells franchises to individuals throughout the United States and provides support in the form of marketing, technology and training to new franchisees. ARCpoint Corporate Labs LLC develops corporate-owned labs committed to providing accurate, cost-effective solutions for customers, businesses and physicians. AFG Services LLC serves as the innovation center of the ARCpoint group of companies as it builds a proprietary technology platform and a physician network to equip all ARCpoint labs with best-in-class tools and solutions to better serve their customers. The platform also digitalizes and streamlines administrative functions such as materials purchasing, compliance, billing and physician services for ARCpoint franchise labs and other clients.
關於 ArcPoint Inc.
ArcPoint是美國領先的特許經營系統,提供藥物測試、酒精篩查、DNA和臨床實驗室測試、企業健康計劃以及就業和背景篩查等服務。該公司總部位於美國南卡羅來納州格林維爾。ArcPoint Francise Group LLC根據南卡羅來納州法律於2005年2月成立,是ArcPoint Labs的特許經營商,爲130多個獨立經營場所提供支持。ArcPoint向美國各地的個人出售特許經營權,並以營銷、技術和培訓的形式向新的加盟商提供支持。ArcPoint Corporate Labs LLC 開發企業自有實驗室,致力於爲客戶、企業和醫生提供準確、具有成本效益的解決方案。AFG Services LLC是ArcPoint集團公司的創新中心,它建立了專有技術平台和醫生網絡,爲所有ArcPoint實驗室配備一流的工具和解決方案,以更好地爲客戶服務。該平台還數字化和簡化了ArcPoint特許經營實驗室和其他客戶的材料採購、合規、計費和醫生服務等管理職能。
For more information, please contact:
欲了解更多信息,請聯繫:
ARCpoint Inc.
Jason Tong, Chief Financial Officer
Phone: (604) 889-7827
E-mail: invest@arcpointlabs.com
ArcPoint Inc
Jason Tong,首席財務官
電話:(604) 889-7827
電子郵件:invest@arcpointlabs.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this Press release.
多倫多證券交易所風險交易所及其監管服務提供商(該術語在交易所政策中定義)均不對本新聞稿的充分性或準確性承擔責任。
Forward-Looking Information
前瞻性信息
This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws. Forward-looking statements relate to future events or future performance and reflect the expectations or beliefs of management of the Company regarding future events. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as "intends" or "anticipates", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "should", "would" or "occur". This information and these statements, referred to herein as "forward‐looking statements", are not historical facts, are made as of the date of this news release and include without limitation, statements regarding discussions of future plans, estimates and forecasts and statements as to management's expectations and intentions with respect to, among other things: CRESSO's future plans as a joint venture entity.
本新聞稿包括某些陳述和信息,這些陳述和信息可能構成適用的加拿大證券法所指的前瞻性信息。前瞻性陳述與未來事件或未來業績有關,反映了公司管理層對未來事件的期望或信念。通常,前瞻性陳述和信息可以通過使用諸如 「打算」 或 「預期」 之類的前瞻性術語來識別,或者某些行爲、事件或結果 「可能」、「應該」、「將」 或 「發生」 的此類詞語和短語的變體或陳述。這些信息和這些陳述,在本文中被稱爲 「前瞻性陳述」,不是歷史事實,是截至本新聞發佈之日發佈的,包括但不限於關於未來計劃、估計和預測討論的聲明,以及關於管理層對CRESSO作爲合資實體的未來計劃等方面的預期和意圖的陳述。
These forward‐looking statements involve numerous risks and uncertainties, and actual results might differ materially from results suggested in any forward-looking statements.
這些前瞻性陳述涉及許多風險和不確定性,實際結果可能與任何前瞻性陳述中建議的結果存在重大差異。
In making the forward-looking statements in this news release, the Company has applied several material assumptions, including without limitation, that: CRESSO will be able to operate as a successful joint venture entity once formed.
在本新聞稿中發表前瞻性陳述時,公司運用了幾項重大假設,包括但不限於:CRESSO成立後將能夠作爲一家成功的合資實體運營。
Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial out-look that are incorporated by reference herein, except in accordance with applicable securities laws. We seek safe harbor.
儘管公司管理層試圖確定可能導致實際業績與前瞻性陳述或前瞻性信息中包含的業績存在重大差異的重要因素,但可能還有其他因素導致業績與預期、估計或預期不符。無法保證此類陳述會被證明是準確的,因爲實際結果和未來事件可能與此類陳述中的預期存在重大差異。因此,讀者不應過分依賴前瞻性陳述和前瞻性信息。提醒讀者,依賴此類信息可能不適合用於其他目的。除非根據適用的證券法,否則公司不承諾更新此處以引用方式納入的任何前瞻性陳述、前瞻性信息或財務展望。我們尋求安全港。